Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

© 2021 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 34 vom: 05. Aug., Seite e2102188
1. Verfasser: Ding, Yuan (VerfasserIn)
Weitere Verfasser: Sun, Zhongquan, Gao, Yong, Zhang, Sitong, Yang, Caixia, Qian, Zhefeng, Jin, Lulu, Zhang, Jiaojiao, Zeng, Cheng, Mao, Zhengwei, Wang, Weilin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article 'immunogenic cell death drug delivery immunotherapy plasmon-driven catalysis stimuli-activation Antineoplastic Agents Drug Carriers Enzyme Inhibitors Immunosuppressive Agents Indoleamine-Pyrrole 2,3,-Dioxygenase
Online verfügbar Volltext